alpha-aminopyridine has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, H; Hayashi, H; Ishiki, A; Kawakatsu, S; Kobayashi, R; Okamura, N; Otani, K | 1 |
Jung, SH; Ryu, WS; Sun, X; Yang, BS | 1 |
1 review(s) available for alpha-aminopyridine and Atrophy
Article | Year |
---|---|
[
Topics: Aged; Aminopyridines; Aniline Compounds; Aphasia, Primary Progressive; Atrophy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Quinolines; Semantics; Temporal Lobe; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2018 |
1 other study(ies) available for alpha-aminopyridine and Atrophy
Article | Year |
---|---|
Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminopyridines; Animals; Anti-Inflammatory Agents; Atrophy; Dasatinib; Dermatitis, Allergic Contact; Drug Evaluation; Female; Mice; Mice, Hairless; Mice, Inbred BALB C; Oxazolone; Protein Kinase Inhibitors; Pyrimidines; Skin; Thiazoles; Thiophenes | 2013 |